StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.10−0.01 (-0.47%)

Close on Nov 18, 2026Market cap $213.66MP/E –Yield –

AC Immune cash

Cash and short-term investments held at the end of each period.

AC Immune's cash was CHF 27.76M at Jun 30, 2026. For fiscal 2025 it was CHF 26.80M, down 26.1% from the year before. Over ten years it grew -10.0% a year on average. The highest annual figure on record is CHF 193.59M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 26.80M-26.1%
FY2024Dec 31, 2024CHF 36.28M-53.8%
FY2023Dec 31, 2023CHF 78.49M+148.5%
FY2022Dec 31, 2022CHF 31.59M-61.6%
FY2021Dec 31, 2021CHF 82.22M-48.9%
FY2020Dec 31, 2020CHF 160.89M-16.9%
FY2019Dec 31, 2019CHF 193.59M+23.7%
FY2018Dec 31, 2018CHF 156.46M+25.8%
FY2017Dec 31, 2017CHF 124.38M-18.3%
FY2016Dec 31, 2016CHF 152.21M+98.9%
FY2015Dec 31, 2015CHF 76.52M+2214.6%
FY2014Dec 31, 2014CHF 3.31M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 27.76M-46.2%
Q4 FY2025Dec 31, 2025CHF 26.80M-65.9%
Q2 FY2025Jun 30, 2025CHF 25.72M-35.7%
Q4 FY2024Dec 31, 2024CHF 36.28M+14.8%
Q2 FY2024Jun 30, 2024CHF 51.56M+15.9%
Q4 FY2023Dec 31, 2023CHF 78.49M+24.3%
Q2 FY2023Jun 30, 2023CHF 40.01M-51.3%
Q4 FY2022Dec 31, 2022CHF 31.59M-66.2%
Q3 FY2022Sep 30, 2022CHF 44.50M-72.3%
Q2 FY2022Jun 30, 2022CHF 63.15M-67.4%
Q4 FY2021Dec 31, 2021CHF 82.22M-47.5%
Q3 FY2021Sep 30, 2021CHF 93.58M-24.8%
Q4 FY2020Dec 31, 2020CHF 160.89M+5.7%
Q4 FY2019Dec 31, 2019CHF 193.59M+153.0%
Q4 FY2018Dec 31, 2018CHF 156.46M+4632.7%
Q4 FY2017Dec 31, 2017CHF 124.38M–
Q4 FY2016Dec 31, 2016CHF 152.21M–
Q4 FY2015Dec 31, 2015CHF 76.52M–
Q4 FY2014Dec 31, 2014CHF 3.31M–

More AC Immune figures

See a number that looks wrong?